Boxer Capital, LLC - 10 May 2024 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Other*
Signature
/s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
Issuer symbol
ITOS
Transactions as of
10 May 2024
Net transactions value
+$19,999,998
Form type
4
Filing time
14 May 2024, 21:32:26 UTC
Previous filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Award $19,999,998 +1,142,857 +63% $17.50 2,946,915 10 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.

Remarks:

Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Iteos Therapeutics, Inc. (the "Issuer"). The reporting persons other than Mr. Davis previously reported ceasing to be subject to Section 16 of the Exchange Act with respect to the Issuer. This filing is being made by those other reporting persons without conceding that they are subject to Section 16 of the Exchange Act with respect to the Issuer.